120 related articles for article (PubMed ID: 36785996)
1. Influence of Sex on Early Axial Spondyloarthritis: A Six-Year Longitudinal Analysis From a Large National Cohort.
Aouad K; Tournadre A; Lucasson F; Wendling D; Molto A; Fautrel B; Gossec L
Arthritis Care Res (Hoboken); 2023 Oct; 75(10):2107-2116. PubMed ID: 36785996
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort.
Ciurea A; Scherer A; Exer P; Bernhard J; Dudler J; Beyeler B; Kissling R; Stekhoven D; Rufibach K; Tamborrini G; Weiss B; Müller R; Nissen MJ; Michel BA; van der Heijde D; Dougados M; Boonen A; Weber U;
Arthritis Rheum; 2013 Dec; 65(12):3096-106. PubMed ID: 23983141
[TBL] [Abstract][Full Text] [Related]
3. Differences between women and men with recent-onset axial spondyloarthritis: results from a prospective multicenter French cohort.
Tournadre A; Pereira B; Lhoste A; Dubost JJ; Ristori JM; Claudepierre P; Dougados M; Soubrier M
Arthritis Care Res (Hoboken); 2013 Sep; 65(9):1482-9. PubMed ID: 23463610
[TBL] [Abstract][Full Text] [Related]
4. Brief Report: Clinical Course Over Two Years in Patients With Early Nonradiographic Axial Spondyloarthritis and Patients With Ankylosing Spondylitis Not Treated With Tumor Necrosis Factor Blockers: Results From the German Spondyloarthritis Inception Cohort.
Poddubnyy D; Haibel H; Braun J; Rudwaleit M; Sieper J
Arthritis Rheumatol; 2015 Sep; 67(9):2369-75. PubMed ID: 26017497
[TBL] [Abstract][Full Text] [Related]
5. Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a single rheumatology clinic in New Delhi.
Malaviya AN; Kalyani A; Rawat R; Gogia SB
Int J Rheum Dis; 2015 Sep; 18(7):736-41. PubMed ID: 26172961
[TBL] [Abstract][Full Text] [Related]
6. Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study.
Kilic E; Kilic G; Akgul O; Ozgocmen S
Rheumatol Int; 2015 Jun; 35(6):981-9. PubMed ID: 25366469
[TBL] [Abstract][Full Text] [Related]
7. Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors.
Pedersen SJ; Sørensen IJ; Hermann KG; Madsen OR; Tvede N; Hansen MS; Thamsborg G; Andersen LS; Majgaard O; Loft AG; Erlendsson J; Asmussen K; Johansen JS; Jurik AG; Møller J; Hasselquist M; Mikkelsen D; Skjødt T; Hansen A; Ostergaard M
Ann Rheum Dis; 2010 Jun; 69(6):1065-71. PubMed ID: 19740906
[TBL] [Abstract][Full Text] [Related]
8. A cross-sectional study on clinical characteristics of Saudi axial spondylarthritis: preliminary results.
Bedaiwi MK; AlRasheed RF; Bin Zuair A; Alqurtas EM; Baeshen MO; Omair MA
Eur Rev Med Pharmacol Sci; 2021 Aug; 25(16):5241-5247. PubMed ID: 34486699
[TBL] [Abstract][Full Text] [Related]
9. Early tumor necrosis factor α antagonist therapy in everyday practice for inflammatory back pain suggesting axial spondyloarthritis: results from a prospective multicenter french cohort.
Canouï-Poitrine F; Poulain C; Molto A; Le Thuaut A; Lafon C; Farrenq V; Ferkal S; Le Corvoisier P; Ghaleh B; Bastuji-Garin S; Fautrel B; Dougados M; Claudepierre P
Arthritis Care Res (Hoboken); 2014 Sep; 66(9):1395-402. PubMed ID: 24664935
[TBL] [Abstract][Full Text] [Related]
10. Fibromyalgia in Spondyloarthritis: Effect on Disease Activity Assessment in Clinical Practice.
Wach J; Letroublon MC; Coury F; Tebib JG
J Rheumatol; 2016 Nov; 43(11):2056-2063. PubMed ID: 27633820
[TBL] [Abstract][Full Text] [Related]
11. Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis.
Salaffi F; Ciapetti A; Carotti M; Gasparini S; Citera G; Gutierrez M
Health Qual Life Outcomes; 2014 Aug; 12():129. PubMed ID: 25146299
[TBL] [Abstract][Full Text] [Related]
12. Validity of the ankylosing spondylitis disease activity score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme.
Fernández-Espartero C; de Miguel E; Loza E; Tomero E; Gobbo M; Descalzo MA; Collantes-Estévez E; Mulero J; Muñoz-Fernández S; Zarco P; Carmona L;
Ann Rheum Dis; 2014 Jul; 73(7):1350-5. PubMed ID: 23709245
[TBL] [Abstract][Full Text] [Related]
13. Comparison of ankylosing spondylitis and non-radiographic axial spondyloarthritis in a multi-ethnic Asian population of Singapore.
Hong C; Kwan YH; Leung YY; Lui NL; Fong W
Int J Rheum Dis; 2019 Aug; 22(8):1506-1511. PubMed ID: 31090201
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Association Between Disease Activity and Disability in Early Axial Spondyloarthritis: Results From a Prospective Observational Study of Inflammatory Back Pain.
Carvalho PD; Ruyssen-Witrand A; Marreiros A; Machado PM
Arthritis Care Res (Hoboken); 2022 May; 74(5):768-775. PubMed ID: 33207078
[TBL] [Abstract][Full Text] [Related]
15. Achievement rate and predictive factors of the recommended therapeutical target in patients with axial spondyloarthritis who remain on biological therapy: a prospective cohort study in Spain.
Benavent D; Franco-Gómez K; Plasencia-Rodriguez C; Novella-Navarro M; Bogas P; Nieto R; Monjo I; Nuño L; Villalba A; Peiteado D; Balsa A; Navarro-Compán V
BMJ Open; 2022 Apr; 12(4):e057850. PubMed ID: 35487753
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and consequences of psoriasis in recent axial spondyloarthritis: an analysis of the DESIR cohort over 6 years.
Lucasson F; Richette P; Aouad K; Ryussen-Witrand A; Wendling D; Fautrel B; Gossec L
RMD Open; 2022 Jan; 8(1):. PubMed ID: 35091462
[TBL] [Abstract][Full Text] [Related]
17. Role of Metrology in Axial Spondyloarthritis: Does It Provide Unique Information in Assessing Patients and Predicting Outcome? Results From the British Society for Rheumatology Biologic Register for Ankylosing Spondylitis.
Biallas RL; Dean LE; Davidson L; Hollick R; Pathan E; Robertson L; Jones GT; Macfarlane GJ; Rotariu O
Arthritis Care Res (Hoboken); 2022 Apr; 74(4):665-674. PubMed ID: 33140891
[TBL] [Abstract][Full Text] [Related]
18. Undifferentiated spondyloarthritis vs ankylosing spondylitis and psoriatic arthritis: a real-life prospective cohort study of clinical presentation and response to treatment.
Paramarta JE; De Rycke L; Ambarus CA; Tak PP; Baeten D
Rheumatology (Oxford); 2013 Oct; 52(10):1873-8. PubMed ID: 23861532
[TBL] [Abstract][Full Text] [Related]
19. Eligibility criteria for biologic disease-modifying antirheumatic drugs in axial spondyloarthritis: going beyond BASDAI.
Marona J; Sepriano A; Rodrigues-Manica S; Pimentel-Santos F; Mourão AF; Gouveia N; Branco JC; Santos H; Vieira-Sousa E; Vinagre F; Tavares-Costa J; Rovisco J; Bernardes M; Madeira N; Cruz-Machado R; Roque R; Silva JL; Marques ML; Ferreira RM; Ramiro S
RMD Open; 2020 Jan; 6(1):. PubMed ID: 32144137
[TBL] [Abstract][Full Text] [Related]
20. Does gender influence outcome measures similarly in patients with spondyloarthritis? Results from the ASAS-perSpA study.
Benavent D; Capelusnik D; Ramiro S; Molto A; López-Medina C; Dougados M; Navarro-Compán V
RMD Open; 2022 Sep; 8(2):. PubMed ID: 36096523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
